首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1
【24h】

Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1

机译:microRNA-204的失调通过调节FOXC1介导子宫内膜癌的迁移和侵袭

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

MicroRNAs (miRNAs) regulate mRNA stability and protein expression, and certain miRNAs have been demonstrated to act either as oncogenes or tumor suppressors. Differential miRNA expression signatures have been documented in many human cancers but the role of miRNAs in endometrioid endometrial cancer (EEC) remains poorly understood. This study identifies significantly dysregulated miRNAs of EEC cells, and characterizes their impact on the malignant phenotype. We studied the expression of 365 human miRNAs using Taqman low density arrays in EECs and normal endometriums. Candidate differentially expressed miRNAs were validated by quantitative real-time PCR. Expression of highly dysregulated miRNAs was examined in vitro through the effect of anti-/pre-miRNA transfection on the malignant phenotype. We identified 16 significantly dysregulated miRNAs in EEC and 7 of these are novel findings with respect to EEC. Antagonizing the function of miR-7, miR-194 and miR-449b, or overexpressing miR-204, repressed migration, invasion and extracellular matrix-adhesion in HEC1A endometrial cancer cells. FOXC1 was determined as a target gene of miR-204, and two binding sites in the 3′-untranslated region were validated by dual luciferase reporter assay. FOXC1 expression was inversely related to miR-204 expression in EEC. Functional analysis revealed the involvement of FOXC1 in migration and invasion of HEC1A cells. Our results present dysfunctional miRNAs in endometrial cancer and identify a crucial role for miR-204-FOXC1 interaction in endometrial cancer progression. This miRNA signature offers a potential biomarker for predicting EEC outcomes, and targeting of these cancer progression- and metastasis-related miRNAs offers a novel potential therapeutic strategy for the disease.
机译:MicroRNA(miRNA)调节mRNA的稳定性和蛋白质表达,并且某些miRNA已被证明可以作为癌基因或抑癌基因。在许多人类癌症中均已记录了差异性miRNA表达特征,但对miRNA在子宫内膜样子宫内膜癌(EEC)中的作用仍知之甚少。这项研究确定EEC细胞的miRNA严重失调,并表征其对恶性表型的影响。我们研究了使用Taqman低密度阵列在EEC和正常子宫内膜中表达的365种人类miRNA。通过定量实时PCR验证候选差异表达的miRNA。通过抗-/ pre-miRNA转染对恶性表型的影响,在体外检查了高度失调的miRNA的表达。我们在EEC中鉴定出16种明显失调的miRNA,其中7种是关于EEC的新发现。拮抗miR-7,miR-194和miR-449b的功能或过度表达miR-204,可抑制HEC1A子宫内膜癌细胞的迁移,侵袭和细胞外基质粘附。 FOXC1被确定为miR-204的靶基因,并且通过双重荧光素酶报告基因分析验证了3'-非翻译区的两个结合位点。 FOXC1表达与EEC中miR-204表达成反比。功能分析表明FOXC1参与HEC1A细胞的迁移和侵袭。我们的研究结果显示了子宫内膜癌中功能失调的miRNA,并确定了miR-204-FOXC1相互作用在子宫内膜癌进展中的关键作用。这种miRNA标记为预测EEC结果提供了潜在的生物标记,而靶向这些与癌症进展和转移相关的miRNA则为该疾病提供了一种新颖的潜在治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号